The role of Probiotics in allergic diseases

Warner JO: Allergy practice worldwide. a report by the World Allergy Organization Specialty and Training Council. Int Arch Allergy Immunol. 2006, 139 (2): 166-74. 10.1159/000090502.

Lovasi GS: Children living in areas with more street trees have lower prevalence of asthma. J Epidemiol Community Health. 2008, 62 (7): 647-9. 10.1136/jech.2007.071894.

Romagnani S: Thiand Th2 in human diseases. Clin Immunol Immunopathol. 1996, 80 (3 Pt 1): 225-35. 10.1006/clin.1996.0118.

Flohr C, Pascoe D, Williams HC: Atopic dermatitis and the 'hygiene hypothesis'. too clean to be true?. Br J Dermatol. 2005, 152 (2): 202-16. 10.1111/j.1365-2133.2004.06436.x.

Ouwehand AC: Antiallergic effects of probiotics. J Nutr. 2007, 137 (3 Suppl 2): 794S-7S.

Ogden NS, Bielory L: Probiotics. a complementary approach in the treatment and prevention of pediatric atopic disease. Curr Opin Allergy Clin Immunol. 2005, 5 (2): 179-84. 10.1097/01.all.0000162312.64308.fc.

Kirjavainen PV: Aberrant composition of gut microbiota of allergic infants. a target of bifidobacterial therapy at weaning?. Gut. 2002, 51 (1): 51-5. 10.1136/gut.51.1.51.

Kirjavainen PV: Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol. 2001, 32 (1): 1-7. 10.1111/j.1574-695X.2001.tb00526.x.

Bjorksten B: The gastrointestinal flora and the skin--Is there a link?. Pediatr Allergy Immunol. 2001, 12 (Suppi 14): 51-5. 10.1034/j.1399-3038.2001.121412.x.

Sepp E: Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy. 2005, 35 (9): 1141-6. 10.1111/j.1365-2222.2005.02315.x.

Voor T: Atopic sensitization and atopic dermatitis in Estonian and Swedish infants. Clin Exp Allergy. 2005, 35 (2): 153-9. 10.1111/j.1365-2222.2005.02157.x.

Bjorksten B: Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol. 2005, 108 (4): 16-20.

Watanabe S: Differences infecalmicroflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol. 2005, 111 (3): 587-91. 10.1067/mai.2003.105.

Kirjavainen PV, Gibson GR: Healthy gut microflora and allergy. factors influencing development of the microbiota. Ann Med. 1999, 31 (4): 288-92. 10.3109/07853899908995892.

Kalliomaki M, Isolauri E: Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol. 2003, 3 (1): 15-20. 10.1097/00130832-200302000-00003.

He F: Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol. 2001, 30 (1): 43-7. 10.1111/j.1574-695X.2001.tb01548.x.

Ouwehand A, Isolauri E, Salminen S: The role of the intestinal microflora for the development of the immune system in early childhood. Eur J Nutr. 2002, 41 (Suppi 1): I32-7.

Penders J: Molecular finger printing of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clin Exp Allergy. 2006, 36 (12): 1602-8. 10.1111/j.1365-2222.2006.02599.x.

Adlerberth I: Gut microbiota and development of atopic eczema in 3 European birth cohorts. J Allergy Clin Immunol. 2007, 120 (2): 343-50. 10.1016/j.jaci.2007.05.018.

(WHO), FaAOFotUNaWHO: Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. Accessed on December 7, 2006

Winkler P: Molecular and cellular basis of microflora-host interactions. J Nutr. 2007, 137 (3 Suppl 2): 756S-72S.

Flinterman AE: Probiotics have a different immunomodulatory potential in vitro versus ex vivo upon oral administration in children with food allergy. Int Arch Allergy Immunol. 2007, 143 (3): 237-44. 10.1159/000099467.

Prescott SL: Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis. Clin Exp Allergy. 2005, 35 (12): 1557-64.

Taylor AL: Effects of probiotic supplementation for the first 6 months of life on allergen-and vaccine-specific immune responses. Clin Exp Allergy. 2006, 36 (10): 1227-35. 10.1111/j.1365-2222.2006.02553.x.

Enomoto T, Shimizu K, Shimazu S: [Suppression of allergy development by habitual intake offermented milkfoods, evidence from an epidemiological study]. Arerugi. 2006, 55 (11): 1394-9.

Kalliomaki M: Probiotics in primary prevention of atopic disease. a randomised placebo-controlled trial. Lancet. 2001, 357 (9262): 1076-9. 10.1016/S0140-6736(00)04259-8.

Kalliomaki M: Probiotics and prevention of atopic disease. 4-yearfollow-up of a randomised placebo-controlled trial. Lancet. 2003, 361 (9372): 1869-71. 10.1016/S0140-6736(03)13490-3.

Kalliomaki M: Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007, 119 (4): 1019-21. 10.1016/j.jaci.2006.12.608.

Lodinova-Zadnikova R: [Influence of oral colonization with probiotic E. coli strain after birth on frequency of recurrent infections, allergy and development of some immunologic parameters. Long-term studies]. Ceska Gynekol. 2004, 69 (Suppi 1): 91-7.

Lodinova-Zadnikova R, Cukrowska B, Tlaskalova-Hogenova H: Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol. 2003, 131 (3): 209-11. 10.1159/000071488.

Abrahamsson TR: Probiotics in prevention of IgE-associated eczema. a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007, 119 (5): 1174-80. 10.1016/j.jaci.2007.01.007.

Kukkonen K: Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases. a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2007, 119 (1): 192-8. 10.1016/j.jaci.2006.09.009.

Taylor AL: FOXP3 mRNA expression at 6 months of age is higher in infants who develop atopic dermatitis, but is not affected by giving probiotics from birth. Pediatr Allergy Immunol. 2007, 18 (1): 10-9. 10.1111/j.1399-3038.2006.00483.x.

Taylor AL, Dunstan JA, Prescott SL: Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children. a randomized controlled trial. J Allergy Clin Immunol. 2007, 119 (1): 184-91. 10.1016/j.jaci.2006.08.036.

Moro G: A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child. 2006, 91 (10): 814-9. 10.1136/adc.2006.098251.

Osborn DA, Sinn JK: Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev. 2007, CD006475-4

Majamaa H, Isolauri E: Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol. 1997, 99 (2): 179-85. 10.1016/S0091-6749(97)70093-9.

Isolauri E: Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000, 30 (11): 1604-10. 10.1046/j.1365-2222.2000.00943.x.

Kirjavainen PV, Salminen SJ, Isolauri E: Probiotic bacteria in the management of atopic disease. underscoring the importance of viability. J Pediatr Gastroenterol Nutr. 2003, 36 (2): 223-7. 10.1097/00005176-200302000-00012.

Passeron T: Prebiotics and synbiotics. two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy. 2006, 61 (4): 431-7. 10.1111/j.1398-9995.2005.00956.x.

Viljanen M: Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants. a double-blind placebo-controlled trial. Allergy. 2005, 60 (4): 494-500. 10.1111/j.1398-9995.2004.00514.x.

Viljanen M: Probiotic effects onfaecal inflammatory markers and onfaecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr Allergy Immunol. 2005, 16 (1): 65-71. 10.1111/j.1399-3038.2005.00224.x.

Rosenfeldt V: Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol. 2003, 111 (2): 389-95. 10.1067/mai.2003.389.

Sistek D: Is the effect of probiotics on atopic dermatitis confined to food sensitized children?. Clin Exp Allergy. 2006, 36 (5): 629-33. 10.1111/j.1365-2222.2006.02485.x.

Brouwer ML: No effects of probiotics on atopic dermatitis in infancy. a randomized placebo-controlled trial. Clin Exp Allergy. 2006, 36 (7): 899-906. 10.1111/j.1365-2222.2006.02513.x.

Folster-Holst R: Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol. 2006, 155 (6): 1256-61. 10.1111/j.1365-2133.2006.07558.x.

Weston S: Effects of probiotics on atopic dermatitis. a randomised controlled trial. Arch Dis Child. 2005, 90 (9): 892-7. 10.1136/adc.2004.060673.

Passeron T, Lacour J: Effects of Probiotics on Atopic Dermatitis. Arch Dis Child. 2005, 20 (4): 171-176.

Gruber C: Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy. 2007, 62 (11): 1270-6. 10.1111/j.1398-9995.2007.01543.x.

Michail S, Onady G, Stolfi A, Johnson T: Efficacy of probiotics in treatment ofpediatric atopic dermatitis a meta-analysis of randomized, controlled trials. 2008, 101 (5): 508-16.

Lee J, Seto D, Bielory L: Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol. 2008, 121 (1): 116-121. 10.1016/j.jaci.2007.10.043.

Giovannini M: A randomized prospective double blind controlled trial on effects of longterm consumption offermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr Res. 2007, 62 (2): 215-20. 10.1203/PDR.0b013e3180a76d94.

Wheeler JG: Immune and clinical impact of Lactobacillus acidophilus on asthma. Ann Allergy Asthma Immunol. 1997, 79 (3): 229-33.

Wang MF: Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr Allergy Immunol. 2004, 15 (2): 152-8. 10.1111/j.1399-3038.2004.00156.x.

Xiao JZ: Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial. Clin Exp Allergy. 2006, 36 (11): 1425-35. 10.1111/j.1365-2222.2006.02575.x.

Xiao JZ: Effect of probiotic Bifidobacterium longum BB536 [corrected] in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo-controlled trial. J Investig Allergol Clin Immunol. 2006, 16 (2): 86-93.

Morita H: Preliminary human study for possible alteration of serum immunoglobulin E production in perennial allergic rhinitis with fermented milk prepared with Lactobacillus gasseri TMCO356. Microbiol Immunol. 2006, 50 (9): 701-6.

Xiao JZ: Changes in plasma TARC levels during Japanese cedar pollen season and relationships with symptom development. Int Arch Allergy Immunol. 2007, 144 (2): 123-7. 10.1159/000103223.

Xiao JZ: Clinical efficacy of probiotic Bifidobacterium longum for the treatment of symptoms of Japanese cedar pollen allergy in subjects evaluated in an environmental exposure unit. Allergol Tnt. 2007, 56 (1): 67-75. 10.2332/allergolint.O-06-455.

Tshida Y: Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study. J Dairy Sci. 2005, 88 (2): 527-33.

Peng GC, Hsu CH: The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr Allergy Tmmunol. 2005, 16 (5): 433-8. 10.1111/j.1399-3038.2005.00284.x.

Helin T, Haahtela S, Haahtela T: No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy. 2002, 57 (3): 243-6. 10.1034/j.1398-9995.2002.1s3299.x.

Tamura M: Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: randomized double-blind, placebo-controlled clinical trial. Tnt Arch Allergy Tmmunol. 2007, 143 (1): 75-82. 10.1159/000098318.